Progress in Neuro-Psychopharmacology & Biological Psychiatry

Papers
(The H4-Index of Progress in Neuro-Psychopharmacology & Biological Psychiatry is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Aberrant individual large-scale functional network connectivity and topology in chronic insomnia disorder with and without depression485
Systemic heterogeneity in autism spectrum disorder revealed by individualized structural covariance network analysis267
Early auditory impairments as a candidate marker of attenuated sensory symptoms of psychosis199
The neuropharmacology of kratom, a novel psychoactive natural product133
Levodopa therapy affects brain functional network dynamics in Parkinson's disease109
Relationships between clinical symptoms, cognitive functioning, and TMS-evoked potential features in patients with major depressive disorder108
DNA methylation of serotonin genes as predictive biomarkers of antidepressant treatment response98
Shared polygenic susceptibility to treatment response in severe affective and psychotic disorders: Evidence from GWAS data sets95
Abnormal ReHo and ALFF values in drug-naïve depressed patients with suicidal ideation or attempts: Evidence from the REST-meta-MDD consortium77
A computational and multi-brain signature for aberrant social coordination in schizophrenia75
Editorial Board74
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review74
Bone marrow mononuclear cell transplant prevents rat depression and modulates inflammatory and neurogenic molecules73
Editorial Board73
Histone deacetylase 4 inhibition ameliorates the social deficits induced by Ephrin-B2 mutation71
Editorial Board70
Oleoylethanolamide attenuates the stress-mediated potentiation of rewarding properties of cocaine associated with an increased TLR4 proinflammatory response68
Neural correlates of mental time travel in individuals with high level of schizotypy65
Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia63
Editorial Board58
Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellum57
A randomized, prospective, active-controlled study comparing intramuscular long-acting paliperidone palmitate versus oral antipsychotics in patients with schizophrenia at risk of violent behavior55
The effect of initial antipsychotic treatment on hippocampal and amygdalar volume in first-episode schizophrenia is influenced by age50
The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients50
Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia50
Evaluation of electroretinography (ERG) parameters as a biomarker for ADHD49
Associations of harsh, unpredictable environment, amygdala connectivity and overeating for children49
Neuronal biomarkers as potential therapeutic targets for drug addiction related to sex differences in the brain: Opportunities for personalized treatment approaches48
Differential role of GABAergic and cholinergic ventral pallidal neurons in behavioral despair, conditioned fear memory and active coping47
The type rather than the daily dose or number of antipsychotics affects the incidence of hyperglycemic progression45
The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways44
Network analysis of internet addiction and sleep disturbance symptoms43
Pharmacogenetics of obsessive-compulsive disorder: Investigations of intragenic and regulatory region genetic variations42
Assessment of cognitive domains in major depressive disorders using the Cambridge Neuropsychological Test Automated Battery (CANTAB): Systematic review and meta-analysis of cross-sectional and longitu41
Sex differences in behavioral and neural responses induced by witnessing social defeat stress during adolescence or adulthood in mice40
Exploring the causal relationship between delirium and sarcopenia using bidirectional two-sample Mendelian randomization study39
Improved recognition memory and reduced inflammation following β-caryophyllene treatment in the Wistar-Kyoto rodent model of treatment-resistant depression39
Neochlorogenic acid ameliorates Alzheimer's disease-like pathology via scavenging oxidative stress and restoring blood-brain barrier function in zebrafish38
Common neural correlates of chronic pain – A systematic review and meta-analysis of resting-state fMRI studies38
2.0104310512543